STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Charlie's Holdings (OTCQB:CHUC) to Discontinue Hemp/CBD Product Sales

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Charlies Holdings (OTCQB:CHUC) announced on November 13, 2025 that it will discontinue sales of all hemp/CBD products and permanently wind down and close its Don Polly division.

The company said the move aims to remove hemp/CBD-related trading restrictions imposed by national exchanges and major U.S. brokers, and to facilitate a potential uplist to a national securities exchange and increase liquidity in Charlies common stock. Management stated Don Polly sales are minor relative to 2026 SBX projections and that the companys non-nicotine SBX disposables are now the primary business focus.

Charlie’s Holdings (OTCQB: CHUC) ha annunciato il 13 novembre 2025 che interromperà la vendita di tutti i prodotti a base di canapa/CBD e chiuderà definitivamente la divisione Don Polly.

L'azienda ha affermato che la misura mira a rimuovere le restrizioni di trading legate a canapa/CBD imposte dalle borse nazionali e dai principali broker statunitensi, e a facilitare un eventuale uplist verso una borsa valori nazionale e aumentare la liquidità delle azioni ordinarie di Charlie’s. La direzione ha dichiarato che le vendite Don Polly sono minori rispetto alle proiezioni SBX 2026 e che i dispositivi SBX non nicotina dell'azienda sono ora il focus principale dell'attività.

Charlie’s Holdings (OTCQB:CHUC) anunció el 13 de noviembre de 2025 que dejará de vender todos los productos de cáñamo/CBD y cerrará de forma permanente su división Don Polly.

La compañía afirmó que la medida tiene como objetivo eliminar las restricciones de negociación relacionadas con cáñamo/CBD impuestas por bolsas nacionales y por los principales corredores de EE. UU., y facilitar una posible cotización en una bolsa de valores nacional y aumentar la liquidez de las acciones comunes de Charlie’s. La gerencia señaló que las ventas de Don Polly son mínimas en relación con las proyecciones SBX 2026 y que los dispositivos SBX sin nicotina de la empresa son ahora el foco principal del negocio.

Charlie’s Holdings (OTCQB: CHUC)2025년 11월 13일 모든 대마/CBD 제품의 판매를 중단하고 Don Polly 부서를 영구적으로 축소 및 폐쇄할 것이라고 발표했다.

회사는 이번 조치가 국내 거래소와 미국 주요 중개사들이 부과한 대마/CBD 관련 거래 제한을 제거하고 국내 증권거래소로의 상장 가능성을 돕고 Charlie’s 보통주 유동성을 높이기 위한 것이라고 말했다. 경영진은 Don Polly 매출이 2026년 SBX 전망에 비해 미미하다고 밝히고, 회사의 비니코닐 SBX 디스포저블이 이제 주요 사업 초점이라고 했다.

Charlie’s Holdings (OTCQB: CHUC) a annoncé le 13 novembre 2025 qu'il mettrait fin à la vente de tous les produits à base de chanvre/CBD et procéderait à la liquidation et à la fermeture définitive de sa division Don Polly.

La société a déclaré que cette mesure vise à supprimer les restrictions de négociation liées au chanvre/CBD imposées par les bourses nationales et les principaux courtiers américains, et à faciliter une éventuelle cotation sur une bourse nationale et à accroître la liquidité des actions ordinaires de Charlie’s. La direction a indiqué que les ventes Don Polly sont minimes par rapport aux projections SBX 2026 et que les dispositifs SBX sans nicotine de l'entreprise constituent désormais l'activité principale.

Charlie’s Holdings (OTCQB:CHUC) gab am 13. November 2025 bekannt, dass es den Verkauf aller Hanf-/CBD-Produkte einstellen und seine Don Polly-Abteilung dauerhaft abwickeln und schließen wird.

Das Unternehmen sagte, die Maßnahme ziele darauf ab, die durch nationale Börsen und große US-Broker auferlegten Handelsbeschränkungen für Hanf/B-CBD zu entfernen und eine mögliche Auflistung an einer nationalen Börse zu erleichtern sowie die Liquidität der Charlie’s Stammaktien zu erhöhen. Das Management erklärte, dass Don Polly-Verkäufe im Verhältnis zu den SBX-Projektionen 2026 gering seien und dass die nicht-nikotinhaltigen SBX-Disposables des Unternehmens nun den Hauptgeschäftsfokus bilden.

Charlie’s Holdings (OTCQB: CHUC) أعلنت في 13 نوفمبر 2025 أنها ستوقف بيع جميع منتجات القنب/CBD وتقلّص وتغلق قسم Don Polly بشكل دائم.

قالت الشركة إن هذه الخطوة تهدف إلى إزالة القيود المفروضة على التداول المرتبطة بالقنب/CBD التي تفرضها البورصات الوطنية وأكبر الوسطاء في الولايات المتحدة، وتسهيل احتمال الارتقاء إلى بورصة وطنية وزيادة سيولة أسهم Charlie’s العادية. وأفاد الإدارة بأن مبيعات Don Polly قليلة مقارنة بتوقعات SBX لعام 2026 وأن أجهزة SBX غير النيكوتينية التابعة للشركة تشكل الآن التركيز الأساسي للأعمال.

Positive
  • Board approved permanent closure of Don Polly division
  • Action intended to remove hemp/CBD trading restrictions and facilitate potential uplist
Negative
  • Discontinuation eliminates Don Polly hemp/CBD revenue stream (company called it a rounding error vs 2026 SBX projections)

Don Polly Division closure will help facilitate uplist to a national securities exchange and will remove hemp/CBD-related products trading restrictions on Charlie's common stock.

COSTA MESA, CA / ACCESS Newswire / November 13, 2025 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today announced that, in preparation for an uplist to a national securities exchange, the Company will discontinue sales of all hemp/CBD-related products and will wind-down and close its Don Polly division.

Under current U.S. federal law, hemp products are federally legal if they contain no more than 0.3% delta-9 THC by dry weight. The Agriculture Improvement Act of 2018 (2018 Farm Bill) removed hemp from the federal Controlled Substances Act, thus establishing hemp as an agricultural commodity that is legal to buy and sell across the United States. Nonetheless, because they categorize hemp/CBD products as "cannabis related," national securities exchanges such as the NYSE American, and many large US brokerages severely restrict companies that conduct business in the hemp/CBD industry.

Accordingly, in order to facilitate Charlie's potential uplist to a national securities exchange and also to increase significantly the liquidity of Charlie's common stock with major US brokers, Charlie's Board of Directors unanimously approved a resolution to discontinue sales of all hemp/CBD-related products and to wind down and close permanently its Don Polly division.

"Charlie's Don Polly Division has historically focused on brands and products in the hemp-derived marketplace, primarily aimed at meeting the needs of the wellness consumer," explained Ryan Stump, Charlie's co-founder and Chief Operating Officer "In recent years, however, the hemp/CBD market segment has become significantly less attractive as the Company's non-nicotine products lines ̶ SBX Disposables in particular ̶ have emerged as Charlie's most important business category. In this environment, we believe the time is right to close our Don Polly Division."

Henry Sicignano, Charlie's President added, "Don Polly's current sales represent little more than a rounding error relative to our 2026 SBX projections. Eliminating the hemp/CBD products stigma that has constrained trading of our stock - and which could also hamper the Company's planned uplist - will significantly benefit Charlie's shareholders."

About Charlie's Holdings, Inc.

Charlie's Holdings, Inc. (OTCQB:CHUC) is an industry leader in the premium vapor products space. The Company's products are sold around the world to select distributors, specialty retailers, and third-party online resellers through subsidiary company Charlie's Chalk Dust, LLC has developed an extensive portfolio of brand styles, flavor profiles, and innovative product formats.

For additional information, please visit Charlie's corporate website at: Chuc.com and the Company's branded online websites: sbxvape.com, CharliesChalkDust.com, enjoypachamama.com, and Pacha.co.

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company's ability to successfully increase sales and enter new markets; whether the Company's PMTA's for its nicotine-containing products will be authorized by the FDA, and the FDA's decisions with respect to the Company's future PMTA's for nicotine products; the Company's ability to manufacture and produce products for its customers; the Company's ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, products containing nicotine substitutes, and products containing cannabidiol; litigation risks from the use of the Company's products; risks of government regulations; the impact of competitive products; and the Company's ability to maintain and enhance its brands, as well as other risk factors included in the Company's most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

Investors Contact:

IR@charliesholdings.com
Phone: 949-570-069

SOURCE: Charlie's Holdings, Inc.



View the original press release on ACCESS Newswire

FAQ

What did Charlie's Holdings (CHUC) announce on November 13, 2025?

Charlies announced it will discontinue all hemp/CBD product sales and permanently close the Don Polly division to facilitate a potential uplist.

Why is CHUC closing the Don Polly division and stopping hemp/CBD sales?

Management said the change aims to remove hemp/CBD-related exchange and brokerage trading restrictions and increase stock liquidity for a potential uplist.

Will the Don Polly closure affect Charlie's core SBX business for CHUC?

The company stated Don Polly sales are minimal relative to 2026 SBX projections and that SBX disposables remain the primary business focus.

Does Charlie's (CHUC) give a timeline for uplisting to a national exchange?

The announcement says the move is to facilitate a potential uplist but does not provide a specific uplist timeline or date.

How might the Don Polly wind-down affect CHUC shareholders' liquidity?

Company management said removing the hemp/CBD stigma should significantly benefit shareholders by improving liquidity with major U.S. brokers.
Charlie S Holdin

OTC:CHUC

CHUC Rankings

CHUC Latest News

CHUC Latest SEC Filings

CHUC Stock Data

83.56M
103.96M
60.39%
4.6%
Tobacco
Consumer Defensive
Link
United States
Costa Mesa